As a PAC Ambassador, Michele recruited dozens of new Ambassadors and PAC Members, including the research & development team and CAR T team. She is also a strong advocate for the industry within the New Jersey life-science and business community, and consistently represented her company at countless events with elected officials and key leaders throughout
Lisa’s colleagues describe her as a “tireless champion of the patient voice.” She offers an invaluable perspective on the human impact of proposed legislation. Her work ensures that J&J can better understand and champion policies that expand patient access.
Denarra plays an important role in supporting Merck’s work on advocacy issues by sharing her personal story and experiences with elected officials and the public. Denarra has focused her advocacy on communities of color and the development of women and girls in STEM. Her work has helped enhance Merck’s story and assisted the Merck government
Tracy is a member of Lilly’s Diabetes and Obesity Corporate Affairs team. They have made a significant impact in increasing access to evidence-based comprehensive obesity care. The team has helped reduce obesity related bias and stigma by engaging the policy community on the importance of person-first language, bias-free imagery, and achieving obesity care access parity.
Christine leads Pfizer’s Biotherapeutics Pharmaceutical Sciences (BTx Pharm Sci) with five global sites and is accountable for overseeing and providing strategic direction and operational implementation for aspects of advancing the Pfizer biologics and vaccines clinical portfolio. Earlier this year, she joined Missouri Governor Mike Parson during his daily COVID-19 briefing and highlighted the role the
(GlaxoSmithKline) – As an active volunteer and supporter of the American Diabetes Association of Oregon for over a decade, Bruce has been a member of the auction committee and helped lead its fundraising efforts. His dedication has never been about product; it’s not about sales, but about strengthening patient advocacy and improving quality care.
(GlaxoSmithKline) – Together with NC BIO, the NC Chamber, and the We Work For Health Initiative, Scott and his colleagues at GSK brought together about 100 business leaders, policy makers and non-profit leaders to celebrate the industry and discuss the sector’s economic impact and opportunities for growth.
Justin is the site lead of Pfizer’s St. Louis, MO office. For the last 15 years, Justin and his team have furthered the understanding of novel biotherapeutics, gene therapies, and vaccines within Pfizer’s R&D organization. There, he has hosted external partners to explain the vital role R&D plays in the biopharmaceutical industry.
Dr. Starling plays the invaluable role in supporting Merck’s work on political and federal advocacy issues by providing not only content expertise on Merck’s portfolio of products and development pipeline, but also helping ensure that the government affairs team is able to educate congressional staff on issues surrounding the innovation ecosystem and Merck’s commitment to
(Pfizer) – Peggy has been traveling to Washington for the past year-and-a-half to push for the enactment of a national tracing program to ensure the integrity of pharmaceutical products throughout the supply chain and has been relied on by numerous members of Congress.